Seqirus Co-Authors First Study to Assess Simultaneous Administration of Seasonal Influenza Vaccine and COVID-19 Vaccine Candidate
"Seqirus is committed to advancing the science underpinning influenza and taking our place on the front line, alongside our public health partners, as a reliable influenza vaccine supplier."
- "Seqirus is committed to advancing the science underpinning influenza and taking our place on the front line, alongside our public health partners, as a reliable influenza vaccine supplier."
- "As a company on the front line of influenza prevention, we're committed to helping protect our communities with our differentiated portfolio of safe and effective influenza vaccines."
- Seqirus produces influenza vaccines across its global manufacturing network, which includes facilities in the U.S., U.K. and Australia.
- As one of the largest influenza vaccine providers in the world, Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness.